How many clinical trials are tracked of alogliptin?

27 trials are tracked, 2 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

alogliptin

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of alogliptin

27 trials tracked of alogliptin: 16 in phase 3 or 4 and 2 with published results. The most-cited published study has 19 citations.

27Trials tracked

16Phase 3 & 4

0Recruiting

2With published results

Phase distribution

Phase 4 2 Phase 3 14 Phase 2 3 Phase 1 4 Other / NA 4

Show 21 more trials

Phase 3 Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes. Completed
Phase 3 Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus Completed
Phase 3 Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics Completed
Phase 3 Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome Completed
Phase 3 Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes Completed
Phase 3 Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus Completed
Phase 3 Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus. Completed
Phase 3 Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 Diabetes Completed
Phase 3 Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus Completed
Phase 3 Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes Completed
Phase 2 Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes. Completed
Phase 2 Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan Completed
Phase 2 Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan Completed
Phase 1 Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus Completed
Phase 1 Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes Completed
Phase 1 A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian Participants Completed
Phase 1 Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants Completed
N/A Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones" Completed
N/A Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus Completed
N/A Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)" Completed
N/A Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI" Completed

Showing the 27 most-cited and recently-updated of 27 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.